| 发明名称 |
Use of 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiologically acceptable salts |
| 摘要 |
1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or a physiologically acceptable salt thereof is used for the manufacture of a medicament for the treatment of fibromyalgia. A preferred salt is 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride.
|
| 申请公布号 |
EP1736158(A2) |
申请公布日期 |
2006.12.27 |
| 申请号 |
EP20060017231 |
申请日期 |
2000.05.16 |
| 申请人 |
DE |
发明人 |
DE;DE;DE;DE;GB |
| 分类号 |
A61P29/02;A61K31/495;C07D405/12;A61K31/00;A61K31/496;A61P1/14;A61P3/04;A61P15/10;A61P21/00;A61P25/00;A61P25/22;A61P25/28;A61P29/00 |
主分类号 |
A61P29/02 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
